Hillsdale Investment Management Inc. Raises Holdings in Nature’s Sunshine Products, Inc. $NATR

Hillsdale Investment Management Inc. boosted its holdings in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 28.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 219,470 shares of the company’s stock after buying an additional 48,666 shares during the quarter. Hillsdale Investment Management Inc. owned approximately 1.25% of Nature’s Sunshine Products worth $4,736,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of NATR. Jane Street Group LLC purchased a new position in Nature’s Sunshine Products during the first quarter valued at approximately $174,000. Geode Capital Management LLC increased its holdings in Nature’s Sunshine Products by 9.4% during the second quarter. Geode Capital Management LLC now owns 317,731 shares of the company’s stock valued at $4,700,000 after buying an additional 27,300 shares during the period. JPMorgan Chase & Co. increased its holdings in Nature’s Sunshine Products by 16.1% during the second quarter. JPMorgan Chase & Co. now owns 228,698 shares of the company’s stock valued at $3,382,000 after buying an additional 31,696 shares during the period. Rhumbline Advisers increased its holdings in Nature’s Sunshine Products by 9.7% during the second quarter. Rhumbline Advisers now owns 21,180 shares of the company’s stock valued at $313,000 after buying an additional 1,875 shares during the period. Finally, Russell Investments Group Ltd. increased its holdings in Nature’s Sunshine Products by 91.9% during the second quarter. Russell Investments Group Ltd. now owns 23,787 shares of the company’s stock valued at $348,000 after buying an additional 11,389 shares during the period. 79.40% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Nature’s Sunshine Products

In other news, EVP Bryant J. Yates sold 19,516 shares of Nature’s Sunshine Products stock in a transaction on Friday, March 13th. The shares were sold at an average price of $24.35, for a total transaction of $475,214.60. Following the completion of the sale, the executive vice president directly owned 85,154 shares in the company, valued at approximately $2,073,499.90. The trade was a 18.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Nathan G. Brower sold 12,015 shares of Nature’s Sunshine Products stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $21.84, for a total transaction of $262,407.60. Following the sale, the executive vice president owned 43,438 shares of the company’s stock, valued at $948,685.92. The trade was a 21.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 50,914 shares of company stock valued at $1,213,613. 3.10% of the stock is currently owned by corporate insiders.

Nature’s Sunshine Products Trading Down 2.6%

NASDAQ NATR opened at $21.28 on Friday. The firm’s fifty day simple moving average is $24.50 and its two-hundred day simple moving average is $23.80. Nature’s Sunshine Products, Inc. has a 12-month low of $12.97 and a 12-month high of $28.14. The firm has a market capitalization of $374.10 million, a P/E ratio of 19.35 and a beta of 0.95.

Nature’s Sunshine Products (NASDAQ:NATR) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.10. Nature’s Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%. The business had revenue of $122.89 million for the quarter, compared to analyst estimates of $122.15 million.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on NATR shares. DA Davidson reaffirmed a “buy” rating and issued a $33.00 price target on shares of Nature’s Sunshine Products in a report on Monday, May 11th. Weiss Ratings lowered shares of Nature’s Sunshine Products from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday. Finally, Canaccord Genuity Group set a $37.00 price target on shares of Nature’s Sunshine Products in a report on Friday, May 8th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $35.00.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.